✦ LIBER ✦

The Construction of a Pharmacokinetic Model to Describe Intravenous and Subcutaneous Supplementation of IgG in Patients with Primary Immunodeficiency (PID)

✍ Scribed by Bexon, M.; Rojavin, M.; Jolles, S.; Ellis, S.; Sawyer, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, efficacy, tolerability, and phar

✍ Borte, M.; Wahn, U.; Farber, C.; Bernatowska, E.; Adams, C.; Andresen, I.; Bende 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Pharmacokinetics (PK) of Human Immunoglo

✍ Stein, M.; Wasserman, R.L.; Melamed, I.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Implications to payers of switch from ho

✍ Gerth, William C; Betschel, Stephen D; Zbrozek, Arthur S 📂 Article 📅 2014 🏛 BC Decker 🌐 English ⚖ 85 KB

Efficacy, Safety and Tolerability of a N

✍ Joseph A. Church; Heinz Leibl; Mark R. Stein; Isaac R. Melamed; Arye Rubinstein; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 443 KB